Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
ContributorsBartelink, Harry; Maingon, Philippe; Poortmans, Philip; Weltens, Caroline; Fourquet, Alain; Jager, Jos; Schinagl, Dominic; Oei, Bing; Rodenhuis, Carla; Horiot, Jean-Claude; Struikmans, Henk; Van Limbergen, Erik; Kirova, Youlia; Elkhuizen, Paula; Bongartz, Rudolf; Miralbell, Raymond; Morgan, David; Dubois, Jean-Bernard; Remouchamps, Vincent; Mirimanoff, René-Olivier; Collette, Sandra; Collette, Laurence
Published inLancet oncology, vol. 16, no. 1, p. 47-56
Publication date2015
Abstract
Keywords
- Adult
- Age Factors
- Australia
- Breast Neoplasms/mortality/pathology/radiotherapy/surgery
- Europe
- Female
- Fibrosis
- Humans
- Intention to Treat Analysis
- Israel
- Kaplan-Meier Estimate
- Mastectomy
- Mastectomy, Segmental/adverse effects/mortality
- Middle Aged
- Neoplasm Recurrence, Local
- Neoplasm Staging
- Patient Selection
- Proportional Hazards Models
- Radiotherapy Dosage
- Radiotherapy, Adjuvant
- Reoperation
- Salvage Therapy
- Time Factors
- Treatment Outcome
Research group
Citation (ISO format)
BARTELINK, Harry et al. Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. In: Lancet oncology, 2015, vol. 16, n° 1, p. 47–56. doi: 10.1016/S1470-2045(14)71156-8
Main files (1)
Article (Published version)
Identifiers
- PID : unige:74124
- DOI : 10.1016/S1470-2045(14)71156-8
- PMID : 25500422
ISSN of the journal1470-2045
